期刊文献+

沙美特罗替卡松干粉剂吸入治疗哮喘140例 被引量:2

Curative effects of salmetorel xinafoate and fluticasone propionate powder inhalation on 140 children with asth- ma
下载PDF
导出
摘要 目的观察沙美特罗替卡松干粉荆吸入治疗儿童哮喘的效果。方法应用沙美特罗替卡松干粉剂吸入治疗4-14岁非急性发作期中、重度哮喘140例,与对照组应用氟替卡松吸入治疗哮喘106例作比较,同时监测肺功能结果治疗组和对照组总有效率分别为99.3%、99.1%,显效率分别为63.7%、56.6%。两组治疗4个月后肺功能第1秒钟用力呼气容积(FEV1)、呼气50%用力肺活量时流速(FEF50%)、最大呼气峰流速(PEF)治疗前相比,均有显著提高(P均<0.01)。结论 应用沙美特罗替卡松干粉刺治疗哮喘具有显著疗效,不良反应少,安全性高。并具有携带、吸药方便,病人易接受,依从性高等优点。 Objective To observe the effects of asthmatic children treated by inhaled salmeterol xinafoate and fluticasone propi-onate powder. Methods One hundred and fourty cases of moderate and severe asthmatic children were treated in non- acute period aged from 4 to 14 years by inhaling salmeterol xinafoate and fluticasone propionate powder, compared with control group treated by flu-ticasone propionate in 106 cases, and the pulmonary function was monitored simultaneously. Results The total effective rate of the treatment group and control group were 99. 3 % , 99. 1 % , respectively.The pulmonary function indexes such as the first one second expiration volume(FEV1), flow velocity of 50 % expiration vital capacity(FEF50%), peak expiration velocity(PEF1) after being treated 4 months was improved significantly compared with those before treatment.The difference between them was statistically significant (P<0.01).Conclusions It is significantly effective, safety,and convenient in inhalation with little side- effects in treatment of asth-matic children by inhaling salmeterol xinafoate and fluticasone propionate powder.
出处 《实用儿科临床杂志》 CAS CSCD 北大核心 2004年第12期1084-1085,共2页 Journal of Applied Clinical Pediatrics
关键词 哮喘 儿童 吸入 氟替卡松 沙美特罗 asthma children inhalation fluticasone salmeterol
  • 相关文献

参考文献8

二级参考文献35

  • 1-.中华医学会呼吸病学分会支气管哮喘防治指南(支气管哮喘的定义、诊断、治疗、疗效判断标准及教育和管理方案)[J].中华结核和呼吸杂志,1997,20:261-264.
  • 2The global initiative for asthma. Global strategy for asthma management and prevention: mechanisms of asthma[ M]. NewYork:National institutes of health, 2002.50- 54.
  • 3Holgate ST,Lackie PM,Davies DE,et ad. The bronchial epithelium as a key regtdator of airway allergy sensitization and remodeling in asthma [J ]. Am J Respir Crit Care Med, 2000, 162:Sl13S117.
  • 4Akizanha H, Airway epithelial cells as regulators of airway inflammatory[J ].Int J Mol Med, 1998,1 : 367-- 378,.
  • 5Trennard SI, Repair mechanisms in asthma[J ], J Allergy Clin Immunol, 1996,98: 278 -- 286.
  • 6Holgate ST, Epithelial damage and response[J], Clin Exp Allergy,2000,30 : 137-141.
  • 7Davies DE. The bronchial epithelium:translating gene and environment interactions in asthma[J ]. Curr Opin Allergy Clin Immunol,2001,1 :67--71.
  • 8Bucchieri F, Lordan J, Richter D, et al. Increased sensitivity of asthmatic bronchial epithelial cells to oxidant-induced injury[J].Am J Respir Crit Care Med,2000,161 : A153.
  • 9Devalia JL, Bayram H, Abdelazizkhair OA. Comparision of ciliary activity and inflammatory mediator release from bronchial epithelial cells of nonatopic nonasthmatics and atopic asthmatic patients, and effect of diesel exhaust particlesin vitro [ J ]. J Allergy Clin Immunol, 1998,102: 771 -- 782.
  • 10Holgate ST, Daavies DE. The conquest of allergy: epithlial mesenchymal interactions in the pathogenesis of asthma[J ]. J Allergy Clin Immunol,2000,105(2): 193-196.

共引文献2564

同被引文献13

  • 1周雅燕,郑跃杰,刘灿霞,高鲁燕,袁雄伟,林书文.联合吸入治疗儿童中重度哮喘疗效观察[J].实用儿科临床杂志,2004,19(12):1035-1037. 被引量:4
  • 2吴曙粤,于波.小儿哮喘门诊患儿的医嘱依从性分析[J].广西医学,2004,26(12):1863-1864. 被引量:3
  • 3WHO/NHLBI Workshop Report.Global initiative for asthma management and prevention:pocket guide for asthma management and prevention in children[M].Maryland:National Institute of Health, National Heart,Lung,and Blood Institute,2002:6-9.
  • 4Eickelberg O,Roth M,Lorx R,et al.Ligand-independent activation of the glucocorticoid receptor by β2-adrenergic receptor agonists in primary human lung fibroblasts and vascular smooth muscle cells[J].J Biol Chem,1999,274(2):1005-1010.
  • 5Van den Berg NJ,Ossip MS,Hederos CA,et al.Salmeterol/fultica-sone propionate (50/100 mcg)in combination in a diskus inhaler (seretide) is effective and safe in children with asthma[J].J Pediatr Pulmonol,2000,30(2):97-105.
  • 6Nelson HS,Chapman KR,Pyke SD,et al.Enhanced synergy between fluticasone propionate and salmeterol inhaled from a single inhaler versus separate inhalers[J].J Allergy Clin Immunol,2003,112(1):29-36.
  • 7Green SA,Spasoff AP,Coleman RA,et al.Sustained activation of a G protein-coupled receptor via anchored agonist binding.Molecular localization of the salmeterol exosite within the 2-adrenergic receptor[J].J Biol Chem,1996,271:24029-24035.
  • 8儿童哮喘防治常规(试行)[J].中华儿科杂志,1998,36(12):747-751. 被引量:2372
  • 9董宗祈.支气管哮喘的肾上腺素能受体及其药物治疗[J].中华儿科杂志,2001,39(6):373-375. 被引量:80
  • 10钟南山,郑劲平,刘晓青,肖正伦,姚婉贞,韩翔,王虹,柳小芳,孙铁英,方保民,缪竟智,王厚东,洪军,柯会兴,张洪胜,钮善福,李善群,顾宇彤,胡洁,张志凤,陈琪,钱桂生,王长征,孙鲲,赵志强,王金平,周泽云.吸入沙美特罗替卡松干粉剂与联合吸入两种干粉剂治疗成人哮喘的疗效和安全性的对照研究[J].中华结核和呼吸杂志,2002,25(6):371-374. 被引量:137

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部